RBM4 promotes pancreas cell differentiation and insulin expression

Area of Science:

• Molecular Biology
• Endocrinology
• Developmental Biology

Background:

• The RNA-binding protein RBM4 regulates alternative splicing of muscle-specific mRNA isoforms.
• Understanding the physiological role of RBM4 is essential for its potential therapeutic applications.

Purpose of the Study:

• To investigate the physiological function of RBM4 in pancreas development and function.
• To elucidate the role of RBM4 in insulin gene expression and pancreatic islet cell differentiation.

Main Methods:

• Gene knockout strategy in mice to disrupt Rbm4 genes.
• Analysis of pancreatic islet size, serum insulin levels, and gene expression in Rbm4-deficient mice.
• In vitro studies using pancreatic acinar AR42J cells to assess RBM4's effect on insulin gene expression and transcription factor splicing.

Main Results:

• Rbm4-deficient mice exhibited hyperglycemia, reduced serum insulin, and smaller pancreatic islets.
• Embryonic pancreases of Rbm4-deficient mice showed aberrant splicing and reduced expression of key differentiation factors.
• RBM4 promoted insulin gene expression in AR42J cells by regulating alternative splicing of Isl1 and Pax4.
• RBM4 overexpression converted AR42J cells into insulin-producing cells and influenced glucose-induced insulin expression.

Conclusions:

• RBM4 plays a critical role in promoting pancreas cell differentiation and endocrine function.
• RBM4 regulates insulin production and glucose metabolism primarily through alternative splicing mechanisms.
• RBM4 is a potential therapeutic target for managing diabetes and other endocrine disorders.